Vision with different presbyopia corrections simulated with a portable binocular visual simulator.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 22 03 2019
accepted: 31 07 2019
entrez: 21 8 2019
pubmed: 21 8 2019
medline: 3 4 2020
Statut: epublish

Résumé

Presbyopes can choose today among different corrections to provide them with functional vision at far and near, and the outcomes and patient satisfaction depend on the selection. In this study, we present a binocular and portable vision simulator, based on temporal multiplexing of two synchronized tunable lenses allowing see-through and programmable visual simulations of presbyopic corrections. Seventeen binocular corrections were tested: 3 Monofocal (Far, Intermediate, Near), 4 Simultaneous Vision (bifocal, trifocal), 2 Monovision (far and near in either eye) and 8 Modified Monovision corrections (Simultaneous vision in one eye, Monofocal in the other eye). Perceived visual quality was assessed through the simulated corrections in 8 cyclopleged subjects who viewed a composite realistic visual scene with high contrast letters and a landscape at far (4 m) and a high contrast text at intermediate (66 cm) and near (33 cm) distances. Perceptual scores were obtained on a scale of 0 to 5 (low to high perceived quality). Perceptual preference was assessed by judging 36 random image pairs (6 repetitions) viewed through 9 binocular presbyopic corrections using two-interval forced choice procedures. The average score, across far and near distances, was the highest for Monovision (4.4±0.3), followed by Modified Monovision (3.4±0.1), Simultaneous Vision (3.0±0.1) and Monofocal corrections (2.9±0.2). However, the mean difference between far and near was lower for Simultaneous Vision and Monovision (0.4±0.1 PS) than Modified Monovision (1.8±0.7) or monofocal corrections (3.3±1.5). A strong significant correlation was found between the perceptual scores and the percentages of energy in focus, for each correction and distance (R = 0.64, p<0.0001). Multivariate ANOVA revealed significant influence of observation distances (p<10-9) and patients (p = 0.01) on Perceptual Score. In conclusion, we have developed a binocular portable vision simulator that can simulate rapidly and non-invasively different combinations of presbyopic corrections. This tool has applications in systematic clinical evaluation of presbyopia corrections.

Identifiants

pubmed: 31430328
doi: 10.1371/journal.pone.0221144
pii: PONE-D-19-08227
pmc: PMC6701771
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0221144

Déclaration de conflit d'intérêts

All authors are founders of "Eyes Vision”, a spin-off company based on the simultaneous vision simulator presented in this study Carlos Dorronsoro and Susana Marcos are inventors in a patent protecting the Simultaneous Vision simulator presented in this study: Patent reference number: US9693679 BB; EP3053512 A4; WO15049402 A1; IN201647014738 A; ES2535126 BA; Priority: Oct 1, 2013; Title: “Miniature Simultaneous Vision Simulator Instrument”; Inventors: Carlos Dorronsoro, José Ramón Alonso, Susana Marcos. Patent licensed to 2Eyes Vision This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.

Références

Optom Vis Sci. 2001 Sep;78(9):646-51
pubmed: 11587198
J Vis. 2007 May 25;7(7):7.1-8
pubmed: 17685803
Ophthalmic Physiol Opt. 2007 Sep;27(5):417-39
pubmed: 17718882
J Refract Surg. 2008 Mar;24(3):287-93
pubmed: 18416264
Trans Am Ophthalmol Soc. 2007;105:36-41; discussion 41-2
pubmed: 18427592
Ophthalmology. 2008 Sep;115(9):1508-16
pubmed: 18538402
J Cataract Refract Surg. 2008 Dec;34(12):2005
pubmed: 19027536
J Cataract Refract Surg. 2009 Feb;35(2):303-11
pubmed: 19185247
Opt Lett. 2009 Sep 1;34(17):2628-30
pubmed: 19724513
Appl Opt. 1992 Jul 1;31(19):3621-6
pubmed: 20725333
J Opt Soc Am A Opt Image Sci Vis. 2010 Nov 1;27(11):A48-55
pubmed: 21045890
Clin Ophthalmol. 2011 Jan 07;5:45-56
pubmed: 21311656
Invest Ophthalmol Vis Sci. 2011 Jul 15;52(8):5273-7
pubmed: 21436279
J Cataract Refract Surg. 2011 Jul;37(7):1305-12
pubmed: 21700107
Clin Exp Optom. 2012 Jan;95(1):54-9
pubmed: 22070196
PLoS One. 2011;6(11):e27031
pubmed: 22073247
Curr Opin Ophthalmol. 2012 Jan;23(1):40-6
pubmed: 22081027
Opt Lett. 2011 Dec 15;36(24):4779-81
pubmed: 22179881
Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):415-22
pubmed: 23233256
J Vis. 2013 May 31;13(6):19
pubmed: 23729770
PLoS One. 2013 Jun 28;8(6):e68236
pubmed: 23840836
J Vis. 2013 Jul 15;13(8):null
pubmed: 23857949
Ophthalmic Physiol Opt. 2014 Jan;34(1):8-29
pubmed: 24205890
PLoS One. 2014 Mar 24;9(3):e93089
pubmed: 24664087
Ophthalmic Physiol Opt. 2014 Jul;34(4):397-426
pubmed: 24716827
Am J Ophthalmol. 2014 Aug;158(2):215-220.e1
pubmed: 24792105
Biomed Opt Express. 2014 Sep 02;5(10):3355-66
pubmed: 25360355
Curr Biol. 2015 Mar 2;25(5):R188-9
pubmed: 25734264
J Cataract Refract Surg. 2015 Apr;41(4):873-7
pubmed: 25840309
Vision Res. 2017 Mar;132:85-96
pubmed: 27484778
J Cataract Refract Surg. 2016 Sep;42(9):1276-1287
pubmed: 27697245
Biomed Opt Express. 2016 Oct 03;7(11):4388-4399
pubmed: 27895981
Vision Res. 2017 Mar;132:3-33
pubmed: 28212982
Biomed Opt Express. 2017 Jun 23;8(7):3410-3425
pubmed: 28717577
Sci Rep. 2019 Feb 7;9(1):1539
pubmed: 30733540
Vision Res. 1998 Jan;38(2):209-29
pubmed: 9536350

Auteurs

Aiswaryah Radhakrishnan (A)

Laboratory of Visual Optics and Biophotonics, Instituto de Óptica, IO-CSIC, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Daniel Pascual (D)

Laboratory of Visual Optics and Biophotonics, Instituto de Óptica, IO-CSIC, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Susana Marcos (S)

Laboratory of Visual Optics and Biophotonics, Instituto de Óptica, IO-CSIC, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Carlos Dorronsoro (C)

Laboratory of Visual Optics and Biophotonics, Instituto de Óptica, IO-CSIC, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH